Published in Adv Immunol on January 01, 2014
Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling. J Cell Biol (2015) 0.88
Insights into cytokine-receptor interactions from cytokine engineering. Annu Rev Immunol (2014) 0.87
Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency. Sci Signal (2015) 0.80
Type I Interferon Signaling Is Decoupled from Specific Receptor Orientation through Lenient Requirements of the Transmembrane Domain. J Biol Chem (2015) 0.77
Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored Workshop. Cancer Epidemiol Biomarkers Prev (2015) 0.77
Absolute Ligand Discrimination by Dimeric Signaling Receptors. Biophys J (2016) 0.75
Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol (2002) 15.33
Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci (1957) 13.46
A diverse range of gene products are effectors of the type I interferon antiviral response. Nature (2011) 12.86
Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol (2010) 11.80
Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol (2005) 11.57
Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J (2003) 10.77
Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science (1992) 7.00
Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol (1997) 6.88
Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med (2005) 6.59
Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science (2006) 6.38
Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov (2007) 6.33
Interferons, interferon-like cytokines, and their receptors. Immunol Rev (2004) 6.21
Foxp3 in control of the regulatory T cell lineage. Nat Immunol (2007) 5.94
Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol (2008) 5.86
New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol (2009) 5.57
Super-resolution fluorescence microscopy. Annu Rev Biochem (2009) 5.47
Interleukin-10 and related cytokines and receptors. Annu Rev Immunol (2004) 5.41
JAK-STAT signaling: from interferons to cytokines. J Biol Chem (2007) 5.28
Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods (2006) 5.25
Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science (1996) 5.19
A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell (1992) 4.96
The JAK-STAT signaling pathway: input and output integration. J Immunol (2007) 4.92
The biology of interleukin-2. Annu Rev Immunol (2008) 4.77
Complex modulation of cell type-specific signaling in response to type I interferons. Immunity (2006) 4.48
Interleukin-10: new perspectives on an old cytokine. Immunol Rev (2008) 3.94
Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc Natl Acad Sci U S A (1985) 3.74
Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell (2008) 3.72
Interleukin-13 in asthma pathogenesis. Immunol Rev (2004) 3.69
Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell (1990) 3.67
Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science (1991) 3.24
IL-12 family cytokines: immunological playmakers. Nat Immunol (2012) 3.12
Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science (1995) 3.10
Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science (1999) 3.03
Erythropoietin receptor activation by a ligand-induced conformation change. Science (1999) 2.98
Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage. Nature (1987) 2.94
Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci U S A (1980) 2.88
High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. J Mol Biol (2007) 2.88
Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science (2003) 2.87
JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity (2012) 2.85
A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem Biophys Res Commun (1989) 2.77
Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature (1995) 2.74
Small peptides as potent mimetics of the protein hormone erythropoietin. Science (1996) 2.70
Interleukin-4 and interleukin-13 signaling connections maps. Science (2003) 2.69
Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat Immunol (2011) 2.67
Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature (1998) 2.65
Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. Science (2005) 2.64
Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol (1995) 2.61
Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol (2004) 2.58
A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell (1991) 2.49
Rational design of potent antagonists to the human growth hormone receptor. Science (1992) 2.45
IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol (2011) 2.44
Structural linkage between ligand discrimination and receptor activation by type I interferons. Cell (2011) 2.39
Homodimerization and constitutive activation of the erythropoietin receptor. Proc Natl Acad Sci U S A (1992) 2.29
Structural biology of shared cytokine receptors. Annu Rev Immunol (2009) 2.27
An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nat Struct Biol (1998) 2.24
Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J (1993) 2.18
Haemopoietic receptors and helical cytokines. Immunol Today (1990) 2.15
Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J Biol Chem (2006) 2.15
The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol Cell (2001) 2.10
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'. Nature (2012) 2.08
IFNgamma signaling-does it mean JAK-STAT? Cytokine Growth Factor Rev (2008) 2.06
Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc Natl Acad Sci U S A (2001) 2.00
Mutational switch of an IL-6 response to an interferon-gamma-like response. Proc Natl Acad Sci U S A (2002) 1.96
Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hemopoietic and nonhemopoietic cells. J Immunol (1988) 1.94
The receptor of the type I interferon family. Curr Top Microbiol Immunol (2007) 1.94
Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J Immunol (2001) 1.93
STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science (1997) 1.92
Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor. J Biol Chem (2004) 1.87
Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem (2002) 1.85
Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol (2005) 1.83
The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell (2008) 1.83
Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity. J Exp Med (2008) 1.83
Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. Mol Cell Biol (2006) 1.82
Role of the Akt pathway in mRNA translation of interferon-stimulated genes. Proc Natl Acad Sci U S A (2008) 1.81
The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction. Trends Endocrinol Metab (1999) 1.79
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J (2003) 1.75
IFNalpha/beta promotes cell survival by activating NF-kappa B. Proc Natl Acad Sci U S A (2000) 1.74
The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif. Mol Cell (2001) 1.72
Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis. J Biol Chem (2001) 1.71
Engineering epidermal growth factor for enhanced mitogenic potency. Nat Biotechnol (1996) 1.68
Hematopoietic receptor complexes. Annu Rev Biochem (1996) 1.67
Covering a broad dynamic range: information processing at the erythropoietin receptor. Science (2010) 1.65
Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol (1998) 1.60
USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response. PLoS One (2011) 1.60
Stat5 signaling specifies basal versus stress erythropoietic responses through distinct binary and graded dynamic modalities. PLoS Biol (2012) 1.59
Involvement of the ubiquitin/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments. Mol Biol Cell (2001) 1.54
Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells. Proc Natl Acad Sci U S A (2010) 1.53
The structure of interleukin-2 complexed with its alpha receptor. Science (2005) 1.53
Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. Biochemistry (1996) 1.52
Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15. J Biol Chem (1995) 1.52
IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25. Proc Natl Acad Sci U S A (2010) 1.50
gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol (2010) 1.48
Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol Cell Biol (1994) 1.47
Mechanistic diversity of cytokine receptor signaling across cell membranes. Sci STKE (2004) 1.42
Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nat Immunol (2012) 1.41
The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor. Proc Natl Acad Sci U S A (1997) 1.40
Amplification of IFN-alpha-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors. Nat Immunol (2004) 1.39
Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130. Mol Cell (2003) 1.38
Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol Rev (2012) 1.38
NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity. J Biol Chem (2006) 1.38